Radioembolization of yttrium-90 microspheres for hepatic malignancy

Ravi Murthy*, Parash Kamat, Rodolfo Nunez, Riad Salem

*Corresponding author for this work

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

The liver represents a frequent site for primary and secondary neoplasia. Cytoreductive techniques positively influence the outcome of disease progression in these patients. Transhepatic arterial radioembolotherapy utilizing yttrium-90 microspheres represents a recently available in situ therapy that has shown encouraging results in the treatment of these patients. Harnessing the skills of many different specialties, such as interventional radiology, surgical oncology, medical oncology, nuclear medicine, radiation oncology, medical physics, and radiation safety, brings invaluable expertise to the treatment process for a safe and effective radioembolization treatment program.

Original languageEnglish (US)
Pages (from-to)48-57
Number of pages10
JournalSeminars in Interventional Radiology
Volume25
Issue number1
DOIs
StatePublished - Mar 1 2008

Fingerprint

Yttrium
Microspheres
Liver
Neoplasms
Interventional Radiology
Radiation Oncology
Medical Oncology
Nuclear Medicine
Physics
Therapeutics
Disease Progression
Radiation
Safety

Keywords

  • Liver cancer
  • Radioembolization
  • Yttrium-90

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Murthy, Ravi ; Kamat, Parash ; Nunez, Rodolfo ; Salem, Riad. / Radioembolization of yttrium-90 microspheres for hepatic malignancy. In: Seminars in Interventional Radiology. 2008 ; Vol. 25, No. 1. pp. 48-57.
@article{208ecdda3ff440ac9fa1dd58ffecb9aa,
title = "Radioembolization of yttrium-90 microspheres for hepatic malignancy",
abstract = "The liver represents a frequent site for primary and secondary neoplasia. Cytoreductive techniques positively influence the outcome of disease progression in these patients. Transhepatic arterial radioembolotherapy utilizing yttrium-90 microspheres represents a recently available in situ therapy that has shown encouraging results in the treatment of these patients. Harnessing the skills of many different specialties, such as interventional radiology, surgical oncology, medical oncology, nuclear medicine, radiation oncology, medical physics, and radiation safety, brings invaluable expertise to the treatment process for a safe and effective radioembolization treatment program.",
keywords = "Liver cancer, Radioembolization, Yttrium-90",
author = "Ravi Murthy and Parash Kamat and Rodolfo Nunez and Riad Salem",
year = "2008",
month = "3",
day = "1",
doi = "10.1055/s-2008-1052306",
language = "English (US)",
volume = "25",
pages = "48--57",
journal = "Seminars in Interventional Radiology",
issn = "0739-9529",
publisher = "Thieme Medical Publishers",
number = "1",

}

Radioembolization of yttrium-90 microspheres for hepatic malignancy. / Murthy, Ravi; Kamat, Parash; Nunez, Rodolfo; Salem, Riad.

In: Seminars in Interventional Radiology, Vol. 25, No. 1, 01.03.2008, p. 48-57.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Radioembolization of yttrium-90 microspheres for hepatic malignancy

AU - Murthy, Ravi

AU - Kamat, Parash

AU - Nunez, Rodolfo

AU - Salem, Riad

PY - 2008/3/1

Y1 - 2008/3/1

N2 - The liver represents a frequent site for primary and secondary neoplasia. Cytoreductive techniques positively influence the outcome of disease progression in these patients. Transhepatic arterial radioembolotherapy utilizing yttrium-90 microspheres represents a recently available in situ therapy that has shown encouraging results in the treatment of these patients. Harnessing the skills of many different specialties, such as interventional radiology, surgical oncology, medical oncology, nuclear medicine, radiation oncology, medical physics, and radiation safety, brings invaluable expertise to the treatment process for a safe and effective radioembolization treatment program.

AB - The liver represents a frequent site for primary and secondary neoplasia. Cytoreductive techniques positively influence the outcome of disease progression in these patients. Transhepatic arterial radioembolotherapy utilizing yttrium-90 microspheres represents a recently available in situ therapy that has shown encouraging results in the treatment of these patients. Harnessing the skills of many different specialties, such as interventional radiology, surgical oncology, medical oncology, nuclear medicine, radiation oncology, medical physics, and radiation safety, brings invaluable expertise to the treatment process for a safe and effective radioembolization treatment program.

KW - Liver cancer

KW - Radioembolization

KW - Yttrium-90

UR - http://www.scopus.com/inward/record.url?scp=42149087133&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42149087133&partnerID=8YFLogxK

U2 - 10.1055/s-2008-1052306

DO - 10.1055/s-2008-1052306

M3 - Article

C2 - 21326493

AN - SCOPUS:42149087133

VL - 25

SP - 48

EP - 57

JO - Seminars in Interventional Radiology

JF - Seminars in Interventional Radiology

SN - 0739-9529

IS - 1

ER -